Andere Sprachen Mind Medicine (MindMed) Inc. Deutsche Boerse AG

Aktien

A3DR6E

CA60255C8850

MMQ

Realtime-Estimate Tradegate Andere Börsenplätze 18:36:45 09.05.2024			% 5 Tage	% 1. Jan.
8.22 ^EUR	-6.75%		-1.50%	+152.96%

08.05.	Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024
08.05.	Mind Medicine (MindMed) Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US	14:03
MindMed Reports First Quarter 2024 Financial Results and Business Updates	08.05.
Mind Medicine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
MindMed ISPOR 2024: Work Productivity and Activity Impairment Associated with Generalized Anxiety Disorder among Adults in the United States	06.05.
MindMed ISPOR 2024: Health-related Quality of Life Associated with Generalized Anxiety Disorder among Adults in the United States	06.05.
MindMed ISPOR 2024: Health Care Resource Use Associated with Generalized Anxiety Disorder among Adults in the United States	06.05.
MindMed APA 2024: Screening Adults in the US General Population to Detect Cases of Undiagnosed Generalized Anxiety Disorder	04.05.
MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York	04.05.
MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update	02.05.
MindMed to Present at Upcoming May Medical Conferences	25.04.
MindMed to Present at Upcoming April Medical Conferences	02.04.
MindMed Announces Voluntary Delisting from Cboe Canada	01.04.
Mind Medicine Inc. announced that it has received $75 million in funding from Deep Track Capital, LP, Commodore Capital	18.03.
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference	11.03.
Numinus Wellness Congratulates Mindmed on Positive Results from Phase 2B Clinical Trials of Mm120 for Generalized Anxiety Disorder	08.03.
Sector Update: Health Care Stocks Gain Late Afternoon	07.03.
Sector Update: Health Care Stocks Stronger in Afternoon Trading	07.03.
Mind Medicine Gets FDA Breakthrough for Anxiety Treatment, Sees $175 Million in Proceeds From Stock Offerings; Shares Jump	07.03.
Mind Medicine MindMed : Investor Presentation - MM120 for Generalized Anxiety Disorder Conference Call and Webcast	07.03.
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mind Medicine (MindMed) Inc. Deutsche Boerse AG

Aktien

A3DR6E

CA60255C8850

MMQ

Andere Sprachen

Filter